Objective-To examine the effect of using two view mammography in comparison with one view mammography in the detection of small «15 mm) invasive cancers. Setting-Screening programme data from National Health Service breast screening programme (NHSBSP). Methods-Data were collated from all screening programmes in the United Kingdom on standard "Korner" returns (KC62 forms) for the screening year 1 April 1994 to 31 March 1995. The comparison of invasive cancer detection rates by programmes using one and two view mammography with indirectly age standardised invasive cancer detection rates. Results-Programmes using two views for women attending their prevalent screen (first screen) in the NHSBSP detected 3% more non-invasive/microinvasive cancers, 7% more large invasive cancers (2':15 mm), and 42% more small invasive cancers «15 mm) than programmes using one view mammography.
Since the inception of the National Health Service breast screening programme (NHS-BSP) individual screening programmes have opted to use either one view (mediolateral oblique) or two view (mediolateral oblique and craniocaudal) mammography for the women's first (prevalent) screen. In a recent randomised controlled trial two view mammography detected 24% more breast cancers than one view mammography. I For the screening year 1 April 1995 to 31 March 1996 all screening programmes used two view mammography for the prevalent screen, though to date very few screening programmes have opted to use two view mammography for subsequent (incident) screens.
One major problem in monitoring the NHS-BSP's ability to detect small invasive cancers has been the inadequacy of data on the size of invasive cancers detected by screening programmes. Information on the size of invasive cancers is included on the annual KC62 return forms produced by each screening programme, but in 1990-91 14% of screen detected invasive cancers did not have the size recorded.' Efforts have been made to improve the completeness of this information and a target ofless than 5% of cancers to be unsized has recently been set." Overall, on the returns from all the 89 screening programmes for 1994-95 for the prevalent screen, only 4.9% of invasive cancers are not sized. As during 1994-95 a large number of programmes still used one view mammography for prevalent screening a more detailed analysis has been undertaken on the detection of small invasive cancers by one and two view mammography.
Methods
MGW collected information on the number of views by telephone. The information on the detection of invasive cancers was taken from the 1994-95 KC62 returns (tables A, B, and G) received from each screening office by the Department of Health and the Cancer Screening Evaluation Unit.
To allow for the confounding effects of screening women of different ages the standardised detection ratio (SDR) measure of invasive cancer detection was used.' The SDR measures the ratio of the observed number of invasive cancers to the expected number of invasive cancers based on applying criteria from the Swedish two county randomised controlled trial.4 It was not possible to calculate the guidelines (Wilson ARM, personal communication) have set an expected standard of at least 50% of invasive cancers to be less than 15 mm in maximum diameter, and the measures SDR-(SIC) and SDR(UC) are an extension of this target. The SDR(SIC) is defined as the observed number of invasive cancers < 15 mm divided by 50% of the total expected number of invasive cancers. The SDR(SIC) is a more rigorous measure than the target it is based on as a programme that detects very few invasive cancers compared with the number expected from the Swedish two county study might still have 50% less than 15 mm. The SDR(UC) is similarly defined as the observed number of invasive cancers~15 rnm divided by 50% of the total expected number of invasive cancers. A further ratio has been introduced to measure the detection of non-invasive/rnicroinvasive cancers, SDR(NONM). The Swedish two county study detected 10.6% of cancers as in situ at the first screen.' The SDR(NONM) is defined as the total number of non-invasive and microinvasive cancers divided by 0.12 times the total number of expected invasive cancers. An SDR(NONM) of 1 indicates a programme detecting the same number of non-invasive! microinvasive cancers expected if the programme were detecting these cancers at the equivalent rate to the Swedish two county study.
Standardised detection ratios of invasive cancers in particular size categories have not been calculated as these will depend on the percentages used to calculate the expected numbers; however, the rate ratio and its associated confidence limits is independent of these percentages and is used to compare the effect of two view and one view mammography for particular size categories of invasive cancers.
Results
Of the 89 screening programmes operating during the screening year 1994-95, 38% (34) used one view mammography and 58% (52) used two view mammography at the prevalent SDR for women aged 50-64 for the 1994-95 KC62 returns and therefore an "all age" SDR was calculated. To date, relatively few women are screened outside the age range 50-64 by the NHSBSP and most of these are aged either 49 or 65 on the actual date of screening. An analysis of 1993-94 data, where both of these measures, could be calculated showed them to be in close agreement. To allow for any confounding effect of the background incidence of breast cancer in the catchment area of each screening programme, correction factors were produced using the Atlas of cancer incidence 1968-85. ' This paper introduces two new measures of invasive cancer detection-the SDR(SIC) for small invasive cancers less than 15 mm in size and the SDR(UC) for large invasive cancers of 15 mm or greater. Recent quality assurance screen; three programmes were not classified. The comparison of one view and two view mammography in the detection of small invasive cancers was based on 65 screening programmes (25 using one view and 40 using two view), each of which had sized at least 90% of the invasive cancers they detected. The 65 programmes detected 1705 invasive cancers, of which 1672 (98%) had size recorded. Table 1 shows the size distribution of the invasive cancers from the 65 screening programmes. Programmes using two views detected 26.9% of invasive cancers <10 mm and 56.1 % <15 mm, compared with 21.7% and 49.1 % respectively for programmes using one view only. The differences were statistically significant (P =0.02 for <10 mm and P =0.007 for <15 mm). Table 2 shows the observed and expected number of invasive cancers by view protocol for the 65 programmes. Overall, the programmes using two view mammography detected 24% (95% CI 12% to 37%) more invasive cancers than those using one view mammography. Table 3 shows more detail of the cancers being detected. There is little difference in the detection of non-invasivel microinvasive cancers by one and two view programmes, with the latter detecting 3% more cancers (95% CI -14% to 24%). The SDRs are 1.98 and 2.05 for one and two views respectively, indicating that the NHSBSP is detecting about twice as many of these cancers in comparison with the Swedish two county study. For the larger invasive cancers ;:>:15 mm there is also a small difference in the number of invasive cancers detected, with two view programmes detecting 7% (95% CI -7% to 24%) more of these cancers. The major difference in detection of cancers is in the detection of small invasive cancers « 15 mm), with programmes using two view mammography de- t SDR = standardised detection ratio.
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tecting 42% (95% CI 23% to 64%) more of these cancers than programmes using one view. Figure 1 shows a histogram of SDR(SIC) for one view and two view programmes respectively. Five (20%) of the one view programmes had an SDR(SIC) greater than one compared with 21 (53%) of the two view programmes. Table 4 shows the rate ratio (the ratio of SDRs) for each size category reported on the KC62 return forms for programmes using two views compared with those using one view. Programmes using two views detected only 2 % more invasive cancers ;:>:20 mm, but this increased to 54% for invasive cancers <10 mm. Table 5 shows similar information to table 3 but with correction factors for background incidence applied to the expected number of invasive cancers. The results, which are similar to those reported in table 3, are based on fewer screening programmes because the method used does not allow correction factors for programmes from Scotland and Northern Ireland.
Discussion
These results indicate that the use of two view mammography may be even more important than has been previously recognised, though there are a number of potential confounding factors not allowed for in the above analysis, such as film density and number of readers.
Film density, which is an important factor affecting image quality, is much less of a potential confounder for 1994-95 than in previous years because nearly all programmes used the recommended film density range of 1.4-1.8 D (Young K, personal communication), and we have not considered this further. The number of mammographic readers is difficult to allow for because of the extreme complexity of the variable. Although most programmes use double reading, the actual percentage of films double read varies between 9% and 100%. In addition, the second reader may not be a radiologist and some programmes use a third reader. The final decision to recall the women can be by consensus opinion, worst opinion, or arbitration by a third radiologist. Further potential confounding variables are the skill of individual radiologists in detecting small invasive cancers and the use of early recall; again these cannot be allowed for in this study. Most screening programmes only diagnose a small number of cancers through early recall, and for 1994-95 fewer than 5% were detected in this category.
For the NHSBSP to achieve its objective of reducing the mortality from breast cancer the detection of small invasive cancers is generally recognised as being of prime importance because it is the detection of these cancers that is likely to result in a reduction in mortality.' The detection of in situ carcinoma and larger invasive cancers is likely to be less important in achieving high mortality reductions. In a recent randomised controlled trial Wald and colleagues reported a median size of 13 mm in the tumours detected by one view and 12 mm in the tumours detected by two views.' However, the total cancer detection rates of 6.84 per view indicated that the absolute number of small cancers (and large cancers) would have been higher in the two view programmes. This contrasts with the results in the present paper, where most of the increased detection with two views is of small invasive cancers. From the radiological point of view the results may not be unexpected. Andersson concluded that the dominating abnormality of non-invasive carcinoma was calcifications, which were always recognised in different projections." The appearance of small tumours, most of which did not show calcifications, varied considerably from one projection to another. Twenty per cent of invasive carcinomas ;::'10 mm in diameter were either not visible or equivocal in one of the two projections used at screening, compared with 7% of larger invasive cancers (> 10 mm). The results presented in this paper concur with these previous observations.
This study highlights the need for accurate and complete sizing of invasive cancers in national screening programmes, such as the NHSBSP, in order to give an early indication of performance rather than waiting for interval cancer information, or a mortality reduction in the population of screened women. In the earlier years of the NHSBSP some programmes were reporting total cancer detection rates in line with those expected but with up to 30% of cancers as carcinoma in situ. The high interval cancers reported by some regions despite high overall cancer detection rates may partly reflect this distribution of detected cancers." III A high detection rate of small invasive cancers, rather than a high overall cancer detection rate, is the crucial factor in achieving a reduction in breast cancer mortality. Results from 1995-96 when 203 all programmes should be using two view mammography for the prevalent screen should indicate whether the benefit of using two view mammography, which is shown in this paper, is further seen in practice. As most women being invited to the NHSBSP are now undergoing incident screens the use of two views for incident screens may need to be considered further.
